Terms: = Leukemia AND DDX10, HRH-J8, 1662, ENSG00000178105, Q13206
22 results:
1. [Acute myeloid leukemia harboring NUP98::ddx10].
Kurita N; Kato T; Nanmoku T; Maruyama Y; Suehara Y; Hattori K; Sakamoto T; Yokoyama Y; Yoshida C; Tsuboi Y; Obara N; Nishikii H; Sakata-Yanagimoto M; Chiba S
Rinsho Ketsueki; 2022; 63(10):1397-1401. PubMed ID: 36351646
[TBL] [Abstract] [Full Text] [Related]
2. Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study.
Gadaud N; Leroy H; Bérard E; Tavitian S; Leguay T; Dimicoli-Salazar S; Rieu JB; Luquet I; Largeaud L; Bidet A; Delabesse E; Klein E; Sarry A; de Grande AC; Bories P; Pigneux A; Récher C; Dumas PY; Bertoli S
Leuk Lymphoma; 2022 Jun; 63(6):1398-1406. PubMed ID: 35634787
[TBL] [Abstract] [Full Text] [Related]
3. CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.
Schmoellerl J; Barbosa IAM; Eder T; Brandstoetter T; Schmidt L; Maurer B; Troester S; Pham HTT; Sagarajit M; Ebner J; Manhart G; Aslan E; Terlecki-Zaniewicz S; Van der Veen C; Hoermann G; Duployez N; Petit A; Lapillonne H; Puissant A; Itzykson R; Moriggl R; Heuser M; Meisel R; Valent P; Sexl V; Zuber J; Grebien F
Blood; 2020 Jul; 136(4):387-400. PubMed ID: 32344427
[TBL] [Abstract] [Full Text] [Related]
4. Clinical outcome of FLAG-IDA chemotherapy sequential with Flu-Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes.
Wang L; Devillier R; Wan M; Decroocq J; Tian L; Fürst S; Wang LN; Vey N; Fan X; Blaise D; Hu J
Bone Marrow Transplant; 2019 Mar; 54(3):458-464. PubMed ID: 30082853
[TBL] [Abstract] [Full Text] [Related]
5. Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia.
Nabbouh AI; Hleihel RS; Saliba JL; Karam MM; Hamie MH; Wu HJM; Berthier CP; Tawil NM; Bonnet PA; Deleuze-Masquefa C; El Hajj HA
Cancer; 2017 May; 123(9):1662-1673. PubMed ID: 28055106
[TBL] [Abstract] [Full Text] [Related]
6. NUP98/11p15 translocations affect CD34+ cells in myeloid and T lymphoid leukemias.
Crescenzi B; Nofrini V; Barba G; Matteucci C; Di Giacomo D; Gorello P; Beverloo B; Vitale A; Wlodarska I; Vandenberghe P; La Starza R; Mecucci C
Leuk Res; 2015 Jul; 39(7):769-72. PubMed ID: 26004809
[TBL] [Abstract] [Full Text] [Related]
7. Inv(11)(p15q22)/NUP98-ddx10 fusion and isoforms in a new case of de novo acute myeloid leukemia.
Gorello P; Nofrini V; Brandimarte L; Pierini V; Crescenzi B; Nozza F; Daniele G; Storlazzi CT; Di Giacomo D; Matteucci C; La Starza R; Mecucci C
Cancer Genet; 2013 Mar; 206(3):92-6. PubMed ID: 23522748
[TBL] [Abstract] [Full Text] [Related]
8. Effects of the NUP98-ddx10 oncogene on primary human CD34+ cells: role of a conserved helicase motif.
Yassin ER; Abdul-Nabi AM; Takeda A; Yaseen NR
Leukemia; 2010 May; 24(5):1001-11. PubMed ID: 20339440
[TBL] [Abstract] [Full Text] [Related]
9. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins.
Takeda A; Sarma NJ; Abdul-Nabi AM; Yaseen NR
J Biol Chem; 2010 May; 285(21):16248-57. PubMed ID: 20233715
[TBL] [Abstract] [Full Text] [Related]
10. Inversion (11)(p15q22) with NUP98-ddx10 fusion gene in pediatric acute myeloid leukemia.
Morerio C; Acquila M; Rapella A; Tassano E; Rosanda C; Panarello C
Cancer Genet Cytogenet; 2006 Dec; 171(2):122-5. PubMed ID: 17116492
[TBL] [Abstract] [Full Text] [Related]
11. NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique.
Romana SP; Radford-Weiss I; Ben Abdelali R; Schluth C; Petit A; Dastugue N; Talmant P; Bilhou-Nabera C; Mugneret F; Lafage-Pochitaloff M; Mozziconacci MJ; Andrieu J; Lai JL; Terre C; Rack K; Cornillet-Lefebvre P; Luquet I; Nadal N; Nguyen-Khac F; Perot C; Van den Akker J; Fert-Ferrer S; Cabrol C; Charrin C; Tigaud I; Poirel H; Vekemans M; Bernard OA; Berger R;
Leukemia; 2006 Apr; 20(4):696-706. PubMed ID: 16467868
[TBL] [Abstract] [Full Text] [Related]
12. Tumor necrosis factor-alpha activates the extrapituitary PRL promoter in myeloid leukemic cells.
Gerlo S; Verdood P; Kooijman R
J Neuroimmunol; 2006 Mar; 172(1-2):206-10. PubMed ID: 16325274
[TBL] [Abstract] [Full Text] [Related]
13. Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization.
Nebral K; König M; Schmidt HH; Lutz D; Sperr WR; Kalwak K; Brugger S; Dworzak MN; Haas OA; Strehl S
Haematologica; 2005 Jun; 90(6):746-52. PubMed ID: 15951287
[TBL] [Abstract] [Full Text] [Related]
14. Clonal evolution with inv(11)(p15q22) and NUP98/ddx10 fusion gene in imatinib-resistant chronic myelogenous leukemia.
Yamamoto M; Kakihana K; Kurosu T; Murakami N; Miura O
Cancer Genet Cytogenet; 2005 Mar; 157(2):104-8. PubMed ID: 15721630
[TBL] [Abstract] [Full Text] [Related]
15. Fusion of the NUP98 gene and the homeobox gene HOXC13 in acute myeloid leukemia with t(11;12)(p15;q13).
Panagopoulos I; Isaksson M; Billström R; Strömbeck B; Mitelman F; Johansson B
Genes Chromosomes Cancer; 2003 Jan; 36(1):107-12. PubMed ID: 12461755
[TBL] [Abstract] [Full Text] [Related]
16. Activation of Akt kinase by granulocyte colony-stimulating factor (G-CSF): evidence for the role of a tyrosine kinase activity distinct from the Janus kinases.
Dong F; Larner AC
Blood; 2000 Mar; 95(5):1656-62. PubMed ID: 10688821
[TBL] [Abstract] [Full Text] [Related]
17. 11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome.
Nishiyama M; Arai Y; Tsunematsu Y; Kobayashi H; Asami K; Yabe M; Kato S; Oda M; Eguchi H; Ohki M; Kaneko Y
Genes Chromosomes Cancer; 1999 Nov; 26(3):215-20. PubMed ID: 10502319
[TBL] [Abstract] [Full Text] [Related]
18. NUP98 is fused to PMX1 homeobox gene in human acute myelogenous leukemia with chromosome translocation t(1;11)(q23;p15).
Nakamura T; Yamazaki Y; Hatano Y; Miura I
Blood; 1999 Jul; 94(2):741-7. PubMed ID: 10397741
[TBL] [Abstract] [Full Text] [Related]
19. The inv(11)(p15q22) chromosome translocation of therapy-related myelodysplasia with NUP98-ddx10 and ddx10-NUP98 fusion transcripts.
Ikeda T; Ikeda K; Sasaki K; Kawakami K; Takahara J
Int J Hematol; 1999 Apr; 69(3):160-4. PubMed ID: 10222653
[TBL] [Abstract] [Full Text] [Related]
20. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia.
Raza-Egilmez SZ; Jani-Sait SN; Grossi M; Higgins MJ; Shows TB; Aplan PD
Cancer Res; 1998 Oct; 58(19):4269-73. PubMed ID: 9766650
[TBL] [Abstract] [Full Text] [Related]
[Next]
